Letrozole is an active pharmaceutical ingredient used in the manufacturing of medications for postmenopausal breast cancer. It functions as an aromatase inhibitor, a class of compounds that play a role in endocrine therapy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Letrozole?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile
pharmaceutical raw material
Gatifloxacin
pharmaceutical raw material
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester
pharmaceutical raw material
24R-calcipotriol
pharmaceutical raw material
The international HS code for Letrozole (CAS 112809-51-5) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
HPJKCIUCZWXJDR-UHFFFAOYSA-N
C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
Sourcing Letrozole?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.